Lipophilic 1-beta-D-arabinofuranosyl cytosine derivatives in liposomal formulations for oral and parenteral antileukemic therapy in the murine L1210 leukemia model (Q71858030)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 January 1996

Language	Label	Description	Also known as
English	Lipophilic 1-beta-D-arabinofuranosyl cytosine derivatives in liposomal formulations for oral and parenteral antileukemic therapy in the murine L1210 leukemia model	scientific article published on 01 January 1996

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8954169%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Lipophilic 1-beta-D-arabinofuranosyl cytosine derivatives in liposomal formulations for oral and parenteral antileukemic therapy in the murine L1210 leukemia model (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8954169%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

0 references

author name string

R A Schwendener

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8954169%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

H Schott

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8954169%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

publication date

1 January 1996

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8954169%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8954169%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

122

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8954169%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8954169%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

723-726

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8954169%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

https://scigraph.springernature.com/pub.10.1007/bf01209119

0 references

Antitumor activity and pharmacology of 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate: an orally active derivative of 1-beta-D-arabinofuranosylcytosine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral antitumour activity in murine L1210 leukaemia and pharmacological properties of liposome formulations of N4-alkyl derivatives of 1-beta-D-arabinofuranosylcytosine

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of leukemia and myelodysplastic syndromes with orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of Myelodysplastic Syndromes with Orally Administered l-β-Z)-Arabinofuranosylcytosine-5’-Stearylphosphate

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cellular pharmacology of a liposomal preparation of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine, a lipophilic derivative of 1-beta-D-arabinofuranosylcytosine

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lipophilic 5'-(alkyl phosphate) esters of 1-beta-D-arabinofuranosylcytosine and its N4-acyl and 2,2'-anhydro-3'-O-acyl derivatives as potential prodrugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacology of l-β-D-arabinofuranosyl cytosine

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell cycle-dependent cytotoxicity and induction of apoptosis by liposomal N4-hexadecyl-1-β-D-arabinofuranosylcytosine

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of Ara-CMP-Stearate (YNK01): phase I study of the oral Ara-C derivative

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characteristic antitumor activity of cytarabine ocfosfate against human colorectal adenocarcinoma xenografts in nude mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthesis and structure-activity studies in vivo of liposomal phospholipid-N4-palmitoyl- and N4-hexadecyl-1-beta-D-arabinofuranosylcytosine conjugates

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cellular pharmacology of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine in the human leukemic cell lines K-562 and U-937

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacology of 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate, an orally administered long-acting derivative of low-dose 1-beta-D-arabinofuranosylcytosine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of L1210 murine leukemia with liposome-incorporated N4-hexadecyl-1-beta-D-arabinofuranosyl cytosine

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic properties and interactions with blood components of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine (NHAC) incorporated into liposomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of murine L1210 lymphoid leukemia and melanoma B16 with lipophilic cytosine arabinoside prodrugs incorporated into unilamellar liposomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01209119

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8954169%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8954169%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q71858030&oldid=1751956708"